MMP9 and liver dysplastic nodule: Recently, we demonstrated that GYY4137 (GYY), a H2S donor, mitigates adverse ECM remodeling by decreasing MMP-9 and MMP-13 expression in the kidney during type-1 DN and also regulates hypertensive ECM remodeling in mouse mesangial cells [13,57].